Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights.
New York, NY (PRWEB) May 09, 2013
The prescription device safety center at DrugRisks.com is announcing updated information on the site for women using the IUD contraceptive Mirena. Patients are advised that experts have warned of perforation injuries and some have already filed legal claims*.
DrugRisks was created to improve the safety of patients using prescription medication devices, such as IUD contraceptives, with the latest safety alerts, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.
The resource center contains a warning by the FDA that the procedure of inserting the Mirena IUD can result in perforation of reproductive organs*.
DrugRisks has also added a study by the Journal of the Society of Laparoendoscopic Surgeons cautioning patients about the migration and perforation of Mirena IUDs that can occur after the device has been implanted**.
The site has also been updated with a warning by the American Journal of Obstetrics and Gynecology for women who must undergo surgery to remove an IUD like Mirena after the devices dislodge and perforate into the abdominal cavity***.
As the number of patients filing a Mirena lawsuit alleging perforation injuries grows, the Judicial Panel on Multidistrict Litigation consolidated all federal cases to a special court in the Southern District of New York (In Re: Mirena IUD Products Liability Litigation, MDL No. 2434)****. Now, that court has scheduled an initial conference for May 17th and ordered counsel to file Position Statements no later than May 11, 2013.
Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights. Due to the specialized nature of federal MDL drug injury cases, DrugRisks only recommends lawyers who are already handling Mirena lawsuits.
*FDA, July 2008; http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121936.htm
**JSLS March, 2011; ncbi.nlm.nih.gov/pmc/articles/PMC3134688/
***AJOG 3/4/13; ajog.org/article/S0002-9378%2813%2900236-6/abstract
****JPML 4/8/13; jpml.uscourts.gov/sites/jpml/files/MDL-2434-Initial_Transfer-03-13.pdf